BioEconomy Investor Will be Hosting Gevo, Inc.'s CEO, Dr. Patrick Gruber on January 18th, 2018 as Part of the alphaDIRECT BioEconomy Investor Virtual Conference Series

Companies Mentioned:

Primary Exchange: NASDAQ
Under the Symbol: GEVO

$2.53

($0.0450)

-1.7476


BioEconomy Investor Will be Hosting Gevo, Inc.'s CEO, Dr. Patrick Gruber on January 18th, 2018 as Part of the alphaDIRECT BioEconomy Investor Virtual Conference Series

Tuesday, January 16, 2018 2:00 PM

SAN FRANCISCO, CA / ACCESSWIRE / January 16, 2018 / alphaDIRECT BioEconomy Investor, a research and Investor Intelligence firm, announced today that Dr. Patrick Gruber, Chief Executive Officer of Gevo, Inc. (NASDAQ: GEVO), will participate in the alphaDIRECT BioEconomy Investor Virtual Conference Series on Thursday, January 18th, 2018 at 11:00 AM PST/ 2:00 PM EST.

Gevo is a leading renewable technology, chemical products, and next generation biofuels company. Gevo has developed proprietary technology that uses a combination of synthetic biology, metabolic engineering, chemistry and chemical engineering to focus primarily on the production of isobutanol, as well as related products from renewable feedstocks.

Investors interested in participating in the event must register using the link below. Please note that registration for the live event is limited but may be accessed at any time for replay after the presentation ends on January 18th, 2018.

Registration Link: https://pgi.webcasts.com/starthere.jsp?ei=1178365&tp_key=85b6c0a4ca

About alphaDIRECT BioEconomy Investor

alphaDIRECT BioEconomy Investor (BEI), a division of alphaDIRECT Advisors, is a research and Investor Intelligence firm that creates and implements digital content and programs to help investors better understand a company's key drivers including industry dynamics, technology, strategy, outlook, and risks as well as the impact they could have on the stock price. BEI's expertise encompasses a variety of sectors including Chemicals and Materials, Fuels, Nutrition, AgTech, Raw Materials, Bioconversion and Manufacturing and Genetics and Genomics. BEI was founded by Wall Street veteran and research analyst, Shawn Severson, after seeing a significant shift in the investment industry that resulted in less fundamental research conducted on small cap companies and a significant decline in information available to all investors. BEI’s mission is to bridge that information gap and engage companies and investors in a way that opens information flow and analytical insights.

To receive complimentary news and updates from alphaDIRECT BioEconomy Investor, please visit: www.bioeconomyinvestor.com.

Sign up to follow alphaDIRECT BioEconomy Investor at: https://twitter.com/BEI_AlphaDirect.

Contact:

alphaDIRECT Advisors
BioEconomy Investor
Shawn M. Severson
+1 415-233-7094
[email protected]
@BEI_AlphaDirect
www.bioeconomyinvestor.com

SOURCE: BioEconomy Investor


Subscribe to alerts from Investor Network
SHARE ARTICLE